Cannabis Suisse Corp. financial data

Symbol
CSUI on OTC
Industry
Papers & Allied Products
Location
10 North Newnan Street, Suite A, Jacksonville, FL
State of incorporation
NV
Fiscal year end
May 31
Former names
Geant Corp. (to 3/29/2019)
Latest financial report
10-Q - Q1 2025 - Apr 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.7 % +4884%
Return On Equity 86.3 % +35.5%
Return On Assets -189 % -176%
Operating Margin -1.06K % -33.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.7M shares +52.8%
Entity Public Float 2.37M USD +1265%
Common Stock, Value, Issued 70.7K USD +52.8%
Weighted Average Number of Shares Outstanding, Basic 70.7M shares +52.8%
Weighted Average Number of Shares Outstanding, Diluted 198M shares +329%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 30K USD 0%
Research and Development Expense 0 USD
General and Administrative Expense 234K USD +627%
Operating Income (Loss) -317K USD -33.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.5M USD -489%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.5M USD -489%
Earnings Per Share, Basic -0.04 USD/shares -300%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50 USD +13.6%
Assets, Current 118K USD +267930%
Property, Plant and Equipment, Net 21.4K USD -16.5%
Operating Lease, Right-of-Use Asset 552K USD +10.3%
Assets 691K USD +31.4%
Accounts Payable, Current 23.3K USD +138%
Accrued Liabilities, Current 58.5K USD +8561%
Liabilities, Current 311K USD -24.1%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 2.54M USD +153%
Retained Earnings (Accumulated Deficit) -3.1M USD -93.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.85M USD -287%
Liabilities and Equity 691K USD +31.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.32K USD -62.7%
Net Cash Provided by (Used in) Financing Activities 2.5K USD -44.4%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 1B shares +300%
Common Stock, Shares, Issued 70.7M shares +52.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.82K USD -329%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 50 USD +13.6%
Deferred Tax Assets, Valuation Allowance 313K USD +47.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 313K USD +47.1%
Operating Lease, Liability 104K USD -56.7%
Depreciation 4.24K USD 0%
Operating Lease, Liability, Current 104K USD -45.1%
Deferred Tax Assets, Operating Loss Carryforwards 1.18M USD +16.5%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 50M shares +150%
Additional Paid in Capital 1.18M USD +9.86%
Preferred Stock, Shares Outstanding 5M shares 0%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 96.3K USD -53.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments Due 107K USD -70.9%
Interest Expense 60.4K USD +245%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%